Summary
This prediction ended on 27.12.18 with a price of €58.91. With a performance of -9.65%, the BUY prediction by mohabbatein finished with a loss. mohabbatein has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Bayer AG | -6.621% | -6.621% | -45.808% | -41.579% |
iShares Core DAX® | 1.195% | 2.111% | 17.166% | 16.919% |
iShares Nasdaq 100 | 3.220% | -1.375% | 22.801% | 33.740% |
iShares Nikkei 225® | 1.858% | 0.888% | 10.064% | -0.682% |
iShares S&P 500 | 2.168% | 0.612% | 22.739% | 38.274% |
Comments by mohabbatein for this prediction
In the thread Bayer AG diskutieren
mohabbatein stimmt dem Sentiment von 'Buy' zu
BAYER leidet gerade wie die meisten anderen Aktien unter der Marktherbstdepression. Hinzu kommt natürlich die Monsanto-Krise. Hier wurde mit dem jüngsten Gerichtsurteil aus US etwas die Toxizität abgelassen.
Glücklich, wer noch Cash zum Investieren in Qualitätstitel hat.
BUY.